Methods to Access 2-aminobenzimidazoles of Medicinal Importance

(a) Enumula, S.; Pangal, A.; Gazge, M.; Javed, A.; Shaikh, J.A.; Ahmed, K. Diverse pharmacological aspects of benzimidazole derivatives: A review. Res. J. Chem. Sci., 2014, 4, 78-88.
(b) Srestha, N.; Banerjee, J.; Srivastava, S. A review on chemistry and biological significance of benzimidazole nucleus. IOSR J. Pharm., 2014, 4, 28-41.
(c) Yerragunta, V.; Patil, P.; Srujana, S.; Devi, R.; Srujana, G.R.; Divya, A. Benzimidazole derivatives and its biological importance: A review. PharmaTutor, 2014, 2, 109-113.
(d) Hamiduzzaman, M.; Mannan, S.J.; Dey, A.; and Rahman, A.S.M. Evaluation of analgesic, antipyretic, hypoglycemic and CNS depressant activity of 2-bromopopylamine hydrobromide, 3-bromopopyl ammonium bromide, ortho-amino aniline and benzimidazole-2-thiol in animal model. Der Pharm. Lett., 2014, 6, 47-53.
(e) Arulmurugan, S.; Kavitha, H.P.; Sathishkumar, S.; Arulmozhi, R. Biologically active benzimidazole derivatives. Mini Rev. Org. Chem., 2015, 12, 178-195.
[http://dx.doi.org/10.2174/1570193X1202150225153403]
(f) Naga, P.K.; Kumar, K.R. Green synthesis of benzimidazole derivatives: An overview of bulk drug synthesis. Int. J. Pharm. Tech. Res., 2015, 8, 60-68.
(g) Wang, Y-T.; Qin, Y-J.; Yang, N.; Zhang, Y-L.; Liu, C.H.; Zhu, H.L. Synthesis, biological evaluation, and molecular docking studies of novel 1-benzene acyl-2-(1-methylindol-3-yl)-benzimidazole derivatives as potential tubulin polymerization inhibitors. Eur. J. Med. Chem., 2015, 99, 125-137.
[http://dx.doi.org/10.1016/j.ejmech.2015.05.021] [PMID: 26070164]
(h) Fatmah, A. S. Evaluation of selected benzimidazole derivatives as potential antimicrobial agents. Molecules,, 2015, 20, 15206-15223.
(i) Maiti, B.; Chanda, K. Diversity oriented synthesis of benzimidazolebased biheterocyclic molecules by combinatorial approach: A critical review. RSC Adv, 2016, 6, 50384-50413.
[http://dx.doi.org/10.1039/C6RA06930D]
(j) Gaba, M.; Mohan, C.H. Development of drugs based on imidazole and benzimidazole bioactive heterocycles: Recent advances and future directions. Med. Chem. Res., 2016, 25, 173-210.
[http://dx.doi.org/10.1007/s00044-015-1495-5]
(k) Keri, R.S.; Rajappa, C.K.; Patil, S.A.; Nagaraja, B.M. Benzimidazolecore as an antimycobacterial agent. Pharmacol. Rep., 2016, 68, (6), 1254- 1265.
[http://dx.doi.org/10.1016/j.pharep.2016.08.002] [PMID: 27686965]
(l) Aishwarya, M.N.L.; Rao, E.A.; Babu, M.N. A Review on gastro-intestinal drug esomeprazole. Pharm. Tutor, 2017, 5, 19-26.
(m) Rajasekhar, S.; Maiti, B.; Balamurali, M.M.; Chanda, K. Synthesis and medicinal applications of benzimidazoles: An overview. Curr. Org. Synth, 2017, 14, 40-60.
[http://dx.doi.org/10.2174/1570179413666160818151932]
(n) Alaqueel, Sh.I. Synthetic approaches to benzimidazoles from ophenylenediamine: A literature review. J. Saudi Chem. Soc, 2017, 21, 229- 237.
[http://dx.doi.org/10.1016/j.jscs.2016.08.001]

(a) Al-Muhaimeed, H. A parallel-group comparison of astemizole and loratadine for the treatment of perennial allergic rhinitis. J. Int. Med. Res., 1997, 25(4), 175-181.
[http://dx.doi.org/10.1177/030006059702500401] [PMID: 9283989]
(b) Ramalingan, C.; Balasubramanian, S.; Kabilan, S. A convenient synthesis of novel 1-[2-(benzimidazol-2-yl)ethoxy]-2,6-diarylpiperidin-4-ones. Synth. Commun., 2004, 34, 1105-1116.
[http://dx.doi.org/10.1081/SCC-120028643]

(a) Martin, R.J. Modes of action of anthelmintic drugs. Vet. J., 1997, 154, 11-34.
(b) Pittman, J.S. Effect of fenbendazole on shedding and embryonation of Ascaris suum eggs in naturally infected gestating sows; 2014.

Wahe, H.; Asobo, P.F.; Cherkasov, R.A.; Nkengfack, A.E.; Folefoc, G.N.; Fomumb, Z.T.; Doepp, D. Heterocycles of biological importance. Part 6. The formation of novel biologically active pyrimido [1,2-a] benzimidazoles from electron deficient alkynes and 2-aminobenzimidazoles. ARKIVOC, 2003, 14, 170-177.

Beaulieu, C.; Wang, Z.; Denis, D.; Greig, G.; Lamontagne, S.; O’Neill, G.; Slipetz, D.; Wang, J. Benzimidazoles as new potent and selective DP antagonists for the treatment of allergic rhinitis. Bioorg. Med. Chem. Lett., 2004, 14, 3195-3199.
[http://dx.doi.org/10.1016/j.bmcl.2004.04.005]

(a) Janssens, F.; Torremans, J.; Janssen, M.; Stokbroekx, R.A.; Luyckx, M.; Janssen, P.A. New antihistaminic N-heterocyclic 4-piperidinamines. 1. Synthesis and antihistaminic activity of N-(4-piperidinyl)-1H-benzimidazol-2-amines. J. Med. Chem., 1985, 28(12), 1925-1933.
[http://dx.doi.org/10.1021/jm00150a028] [PMID: 4068010]
(b) Mor, M.; Bordi, F.; Silva, C.; Rivara, S.; Zuliani, V.; Vacondio, F.; Rivara, M.; Barocelli, E.; Bertoni, S.; Ballabeni, V.; Magnanini, F.; Impicciatore, M.; Plazzi, P.V. Synthesis, biological activity, QSAR and QSPR study of 2-aminobenzimidazole derivatives as potent H3-antagonists. Bioorg. Med. Chem., 2004, 12(4), 663-674.
[http://dx.doi.org/10.1016/j.bmc.2003.11.030] [PMID: 14759727]

Nawrocka, W.; Zimecki, M. Synthesis and immunotropic activity of some 2-aminobenzimidazoles, Part 4. Arch. Pharm. (Weinheim), 1998, 331(7-8), 249-253.
[http://dx.doi.org/10.1002/(SICI)1521-4184(199807)331:7/8<249:AID-ARDP249>3.0.CO;2-B] [PMID: 9747181]

Sethi, P.; Bansal, Y.; Bansal, G. Synthesis and PASS-assisted evaluation of coumarin-benzimidazole derivatives as potential anti-inflammatory and anthelmintic agents. Med. Chem. Res., 2018, 27, 61-71.
[http://dx.doi.org/10.1007/s00044-017-2036-1]

Charifson, P.S.; Grillot, A-L.; Grossman, T.H.; Parsons, J.D.; Badia, M.; Steve Bellon, S.; David, D.; Deininger, D.D.; Drumm, J.E.; Gross, Ch. H., LeTiran, A., Liao, Y., Mani, N., Nicolau, D.P., Perola, E., Ronkin, S., Shannon, D., Swenson, L. L., Tang, Q., Tessier, P.R., Tian, S-K., Trudeau, M., Wang, T., Wei, Y., Zhang, H., Dean Stamos, D. Novel dual-targeting benzimidazole urea inhibitors of DNA gyrase and topoisomerase IV possessing potent antibacterial activity: Intelligent design and evolution through the judicious use of structure-guided design and stucture-activity relationships. J. Med. Chem., 2008, 51, 5243-5263.
[http://dx.doi.org/10.1021/jm800318d] [PMID: 18690678]

(a) Middleton, T.; Lim, H.B.; Montgomery, D.; Rockway, T.; Tang, H.; Cheng, X.; Lu, L.; Mo, H.; Kohlbrenner, W.E.; Molla, A.; Kati, W.M. Inhibition of human immunodeficiency virus type I integrase by naphthamidines and 2-aminobenzimidazoles. Antiviral Res., 2004, 64(1), 35-45.
[http://dx.doi.org/10.1016/j.antiviral.2004.04.007] [PMID: 15451177]
(b) Dayam, R.; Deng, J.; Neamati, N. HIV-1 integrase inhibitors: 2003-2004 update. Med. Res. Rev., 2006, 26(3), 271-309.
[http://dx.doi.org/10.1002/med.20054] [PMID: 16496343]

(a) Kling, A.; Backfisch, G.; Delzer, J.; Geneste, H.; Graef, C.; Hornberger, W.; Lange, U.E.; Lauterbach, A.; Seitz, W.; Subkowski, T. Design and synthesis of 1,5- and 2,5-substituted tetrahydrobenzazepinones as novel potent and selective integrin alphaVbeta3 antagonists. Bioorg. Med. Chem., 2003, 11(7), 1319-1341.
[http://dx.doi.org/10.1016/S0968-0896(02)00616-8] [PMID: 12628659]
(b) Carpenter, R.D.; Andrei, M.; Lau, E.Y.; Lightstone, F.C.; Liu, R.; Lam, K.S.; Kurth, M.J.; Kurth, M.J. Highly potent, water soluble benzimidazole antagonist for activated alpha 4 beta 1 integrin. J. Med. Chem., 2007, 50(23), 5863-5867.
[http://dx.doi.org/10.1021/jm070790o] [PMID: 17948981]
(c) Cindrić, M.; Jambon, S.; Harej, A.; Depauw, S.; David-Cordonnier, M-H.; Kraljević Pavelić, S.; Karminski-Zamola, G.; Hranjec, M. Novel amidino substituted benzimidazole and benzothiazole benzo[b]thieno-2-carboxamides exert strong antiproliferative and DNA binding properties. Eur. J. Med. Chem., 2017, 136, 468-479.
[http://dx.doi.org/10.1016/j.ejmech.2017.05.014] [PMID: 28525845]

(a) de Dios, A.; Shih, C.; López de Uralde, B.; Sánchez, C.; del Prado, M.; Cabrejas, L.M.M.; Pleite, S.; Blanco-Urgoiti, J.; Lorite, M.J.; C, Nevill., Jr R., Bonjouklian, R., York, J., Vieth, M., Wang, Y., Magnus, N., Campbell, R.M., Anderson, B.D., McCann, D.J., Giera, D.D., Lee, P.A., Schultz, R.M., Li, L.C., Johnson, L.M. and Wolos, J.A. “Design of potent and selective 2-aminobenzimidazoles-based p38alpha MAP kinase inhibitors with excellent in vivo efficacy. J. Med. Chem., 2005, 48, 2270-2273.
(b) Zhong, M.; Bui, M.; Shen, W.; Baskaran, S.; Allen, D.A.; Elling, R.A.; Flanagan, W.M.; Fung, A.D.; Hanan, E.J.; Harris, S.J.; Heumann, S.A.; Hoch, U.; Ivy, S.H.N.; Jacobs, J.W.; Lam, S.; Lee, H.; McDowell, R.S.; Oslob, J.D.; Purkey, H.E.; Romanowski, M.J.; Silverman, J.A.; Tangonan, B.T.; Taverna, P.; Yang, W.; Yoburn, J.C.; Yu, Ch.H.; Zimmerman, K.M.; O’Brien, T.; Lew, W. 2-Aminobenzimidazoles as potent Aurora kinase inhibitors. Bioorg. Med. Chem. Lett., 2009, 19, 5158-5161.
(c) Cee, V.J.; Cheng, A.C.; Romero, K.; Bello, S.; Mohr, C.H.; Whittington, D.A.; Bak, A.; Bready, J.; Caenepeel, S.; Coxon, A.; Deak, J.L.; Fretland, J.; Gu, Y.; Hodousa, B.L.; Huang, X.; Kim, J.L.; Lin, J.; Long, A.M.; Nguyen, H.; Olivieri, P.H.R.; Patel, V.F.; Wang, L.; Zhou, Y.; Hughes, P. Geuns-Meyer, S. Pyridyl-pyrimidine benzimidazole derivatives as potent, selective, and orally bioavailable inhibitors of Tie-2 kinase. Bioorg. Med. Chem. Lett., 2009, 19(2), 424-427.

Fujita, M.; Nakao, Y.; Matsunaga, S.; Seiki, M.; Itoh, Y.; Yamashita, J.; Van Soest, R.W.M.; Fusetani, N.; Ageladine, A. An antiangiogenic matrix metalloproteinase inhibitor from the marine sponge Agelas nakamurai. J. Am. Chem. Soc., 2003, 125(51), 15700-15701.
[http://dx.doi.org/10.1021/ja038025w] [PMID: 14677933]

(a) Chassaing, C.; Berger, M.; Heckeroth, A.; Ilg, T.; Jaeger, M.; Kern, C.; Schmid, K.; Uphoff, M. Highly water-soluble prodrugs of anthelmintic benzimidazole carbamates: Synthesis, pharmacodynamics, and pharmacokinetics. J. Med. Chem., 2008, 51(5), 1111-1114.
[http://dx.doi.org/10.1021/jm701456r] [PMID: 18271517]
(b) Mpamhanga, C.P.; Spinks, D.; Tulloch, L.B.; Shanks, E.J.; Robinson, D.A.; Collie, I.T.; Fairlamb, A.H.; Wyatt, P.G.; Frearson, J.A.; Hunter, W.N.; Gilbert, I.H.; Brenk, R. One scaffold, three binding modes: Novel and selective pteridine reductase 1 inhibitors derived from fragment hits discovered by virtual screening. J. Med. Chem., 2009, 52(14), 4454-4465.
[http://dx.doi.org/10.1021/jm900414x] [PMID: 19527033]
(c) Bharti, N. Shailendra; Gonzalez Garza, M.T.; Cruz-Vega, D.E.; Castro-Garza, J.; Saleem, K.; Naqvi, F.; Maurya, M.R.; Azam, A. Synthesis, characterization and antiamoebic activity of benzimidazole derivatives and their vanadium and molybdenum complexes. Bioorg. Med. Chem. Lett., 2002, 12(6), 869-871.
[http://dx.doi.org/10.1016/S0960-894X(02)00034-3] [PMID: 11958982]
(d) Ravina, E.; Sanchez-Alonso, R.; Fueyo, J.; Baltar, M.P.; Bos, J.; Iglesias, R.; Sanmartin, M.L. Synthesis and potential anthelmintic activity of methyl-5-(4-salicyloyl-piperazin-1-yl)-benzimidazole-2-carbamates. Arzneimittelforschung, 1993, 43(6), 689-694.
[PMID: 8352825]
(e) Townsend, L.B.; Wise, D.S. The synthesis and chemistry of certain anthelmintic benzimidazoles. Parasitol. Today, 1990, 6, 107-112.
[http://dx.doi.org/10.1016/j.bmc.2007.06.017] [PMID: 17600722]

Clément, M.J.; Rathinasamy, K.; Adjadj, E.; Toma, F.; Curmi, P.A.; Panda, D. Benomyl and colchicine synergistically inhibit cell proliferation and mitosis: Evidence of distinct binding sites for these agents in tubulin. Biochemistry, 2008, 47(49), 13016-13025.
[http://dx.doi.org/10.1021/bi801136q] [PMID: 19049291]

Yenjerla, M.; Cox, C.; Wilson, L.; Jordan, M.A. Carbendazim inhibits cancer cell proliferation by suppressing microtubule dynamics. J. Pharmacol. Exp. Ther., 2009, 328(2), 390-398.
[http://dx.doi.org/10.1124/jpet.108.143537] [PMID: 19001156]

(a) Zhao, Y.; Pourgholami, M.H.; Morris, D.L.; Collins, J.G.; Day, A.I. Enhanced cytotoxicity of benzimidazole carbamate derivatives and solubilisation by encapsulation in cucurbit[n]uril. Org. Biomol. Chem., 2010, 8(14), 3328-3337.
[http://dx.doi.org/10.1039/c003732j] [PMID: 20523944]
(b) Spagnuolo, P.A.; Hu, J.; Hurren, R.; Wang, X.; Gronda, M.; Sukhai, M.A.; Di Meo, A.; Boss, J.; Ashali, I.; Beheshti Zavareh, R.; Fine, N.; Simpson, C.D.; Sharmeen, S.; Rottapel, R.; Schimmer, A.D. The antihelmintic flubendazole inhibits microtubule function through a mechanism distinct from Vinca alkaloids and displays preclinical activity in leukemia and myeloma. Blood, 2010, 115(23), 4824-4833.
[http://dx.doi.org/10.1182/blood-2009-09-243055] [PMID: 20348394]
(c) Laryea, D.; Gullbo, J.; Isaksson, A.; Larsson, R.; Nygren, P. Characterization of the cytotoxic properties of the benzimidazole fungicides, benomyl and carbendazim, in human tumour cell lines and primary cultures of patient tumour cells. Anticancer Drugs, 2010, 21, 33-42.
(d) Doudican, N.; Rodriguez, A.; Osman, I.; Orlow, S.J. Mebendazole induces apoptosis via Bcl-2 inactivation in chemoresistant melanoma cells. Mol. Cancer Res., 2008, 6(8), 1308-1315.
[http://dx.doi.org/10.1158/1541-7786.MCR-07-2159] [PMID: 18667591]
(e) Bai, R.Y.; Staedtke, V.; Aprhys, C.M.; Gallia, G.L.; Riggins, G.J. Antiparasitic mebendazole shows survival benefit in 2 preclinical models of glioblastoma multiforme. Neur Oncol., 2011, 13(9), 974-982.
[http://dx.doi.org/10.1093/neuonc/nor077] [PMID: 21764822]

(a) Podunavac-Kuzmanović, S.O.; Cvetković, D.M.; Ćetković, G.S. Antimicrobial activity of cobalt (II) complexes with 2-Aminobenzimidazoles derivatives. 2004, 35, 231-237.
[http://dx.doi.org/10.2298/APT0435231P]
(b) Kukalenko, S.S.; Udovenko, V.A.; Borysova, V.P.; Kulugina, N.L.; Burmakin, N.M.; Andreeva, E.L.U.S.S.R. SU 1,636,414. Odkrytiya Izobret, 11. 1999, 75.

Nikolova, A.; Ivanov, D.; Buyukliev, R.; Konstantinov, S.; Karaivanova, M. Preparation, physicochemical characterization and pharmacological study of novel ruthenium(III) complexes with imidazole and benzimidazole derivatives. Arzneimittelforschung, 2001, 51(9), 758-762.
[PMID: 11642009]

(a) Sudha, S.; Karabacak, M.; Kurt, M.; Cinar, M.; Sundaraganesan, N. Molecular structure, vibrational spectroscopic, first-order hyperpolarizability and HOMO, LUMO studies of 2-aminobenzimidazole. Spectrochim. Acta A Mol. Biomol. Spectrosc., 2011, 84(1), 184-195.
[http://dx.doi.org/10.1016/j.saa.2011.09.028] [PMID: 21981941]
(b) Jornet, D.; Bartovský, P.; Domingo, L.R.; Tormos, R.; Miranda, M.A. Experimental and theoretical studies on the mechanism of photochemical hydrogen transfer from 2-aminobenzimidazole to nπ* and ππ* aromatic ketones. J. Phys. Chem. B, 2010, 114(36), 11920-11926.
[http://dx.doi.org/10.1021/jp1053327] [PMID: 20735030]
(c) Ivanova, B.B. Solid state linear dichroic infrared spectral analysis of benzimidazoles and their N(1)-protonated salts. Spectrochim. Acta A Mol. Biomol. Spectrosc., 2005, 62(1-3), 58-65.
[http://dx.doi.org/10.1016/j.saa.2004.12.011] [PMID: 16257693]

Bansal, Y.; Silakari, O. The therapeutic journey of benzimidazoles: A review. Bioorg. Med. Chem., 2012, 20(21), 6208-6236.
[http://dx.doi.org/10.1016/j.bmc.2012.09.013] [PMID: 23031649]

Nájera, C.; Yus, M. Chiral benzimidazoles as hydrogen bonding organocatalysts. Tetrahedron Lett., 2015, 56, 2623-2633.
[http://dx.doi.org/10.1016/j.tetlet.2015.03.099]

Cruz, A.; Padilla-Martínez, I.I.; García-Báez, E.V.; Guerrero-Muñoz, G. Synthesis and structure of sulfur derivatives from 2-aminobenzimidazole. Molecules, 2014, 19(9), 13878-13893.
[http://dx.doi.org/10.3390/molecules190913878] [PMID: 25255762]

Wright, J.B. The chemistry of the benzimidazoles. Chem. Rev., 1951, 48(3), 397-541.
[http://dx.doi.org/10.1021/cr60151a002] [PMID: 24541208]

Simonov, A.M.; Anisimova, V.A. Synthesis and transformation of 2-aminobenzimidazoles. (review). Chem. Heter. Comp., 1979, 15, 705-723.
[http://dx.doi.org/10.1007/BF00473548]

Rastogi, R. Synthesis, 1983, 11, 861-882.
[http://dx.doi.org/10.1055/s-1983-30546]

Mavrova, A.Ts.; Denkova, P.; Tsenov, Y.A.; Anichina, K.K.; Vutchev, D.I. Synthesis and antitrichinellosis activity of some bis(benzimidazol-2-yl)amines. Bioorg. Med. Chem., 2007, 15(18), 6291-6297.
[http://dx.doi.org/10.1016/j.bmc.2007.06.017] [PMID: 17600722]

Lan, P.F.; Romero, A.; Malcolm, T.S.; Stevens, B.D.; Wodka, D.; Makara, G.M. An efficient method to access 2-substituted benzimidazoles under solvent-free conditions. Tetrahedron Lett., 2008, 49, 1910-1914.
[http://dx.doi.org/10.1016/j.tetlet.2008.01.100]

Iemura, R.; Kawashima, T.; Fukuda, T.; Ito, K.; Tsukamoto, G. Synthesis of 2-(4-substituted-1-piperazinyl)benzimidazoles as H1-antihistaminic agents. J. Med. Chem., 1986, 29(7), 1178-1183.
[http://dx.doi.org/10.1021/jm00157a010] [PMID: 2879912]

Orjales, A.; Mosquera, R.; Labeaga, L.; Rodes, R. New 2-piperazinylbenzimidazole derivatives as 5-HT3 antagonists. Synthesis and pharmacological evaluation. J. Med. Chem., 1997, 40(4), 586-593.
[http://dx.doi.org/10.1021/jm960442e] [PMID: 9046349]

Hong, Y.; Tanoury, G.J.; Wilkinson, S.H.; Bakale, R.P.; Wald, S.A.; Senanayake, C.H. Palladium catalyzed amination of 2-chloro-l,3-azole derivatives: Mild entry to potent H I- antihistaminic norastemizole. Tetrahedron Lett., 1997, 38, 5607-5610.
[http://dx.doi.org/10.1016/S0040-4039(97)01273-2]

Hong, Y.; Senanayake, Ch.H.; Xiang, T.; Vandenbossche, Ch.P.; Tanoury, G.J.; Bakale, R.P.; Wald, S.A. Remarkably selective palladium-catalyzed amination process: Rapid assembly of multiamino based structures. Tetrahedron Lett., 1998, 39, 3121-3124.
[http://dx.doi.org/10.1016/S0040-4039(98)00517-6]

Barrett, I.C.; Kerr, M.A. The high-pressure SNAr reaction of N-p-fluorobenzyl-2-chlorobenzimidazole with amines; An approach to norastemizole and analogues. Tetrahedron Lett., 1999, 40, 2439-2442.
[http://dx.doi.org/10.1016/S0040-4039(99)00290-7]

Senanayake, C.H.H.; Hong, Y.; Xiang, T.; Wilkinson, H.S.; Bakale, R.E.; Jurgens, A.R.; Pippert, M.E.; Butler, H.T.; Wald, S.A. Properly tuned first fluoride-catalyzed TGME-mediated amination process for chloroimidazoles: Inexpensive technology for antihistaminic norastemizole. Tetrahedron Lett., 1999, 40, 6875-6879.
[http://dx.doi.org/10.1016/S0040-4039(99)01350-7]

Hooper, M.W.; Utsunomiya, M.; Hartwig, J.F. Scope and mechanism of palladium-catalyzed amination of five-membered heterocyclic halides. J. Org. Chem., 2003, 68(7), 2861-2873.
[http://dx.doi.org/10.1021/jo0266339] [PMID: 12662063]

Wang, X.; Bhatia, P.A.; Daanen, J.F.; Latsaw, S.P.; Rohde, J.; Kolasa, T.; Hakeem, A.A.; Matulenko, M.A.; Nakane, M.; Uchic, M.E.; Miller, L.N.; Chang, R.; Moreland, R.B.; Brioni, J.D.; Stewart, A.O. Synthesis and evaluation of 3-aryl piperidine analogs as potent and efficacious dopamine D4 receptor agonists. Bioorg. Med. Chem., 2005, 13(15), 4667-4678.
[http://dx.doi.org/10.1016/j.bmc.2005.04.060] [PMID: 15896964]

Pagano, M.A.; Andrzejewska, M.; Ruzzene, M.; Sarno, S.; Cesaro, L.; Bain, J.; Elliott, M.; Meggio, F.; Kazimierczuk, Z.; Pinna, L.A. Optimization of protein kinase CK2 inhibitors derived from 4,5,6,7-tetrabromobenzi-midazole. J. Med. Chem., 2004, 47(25), 6239-6247.
[http://dx.doi.org/10.1021/jm049854a] [PMID: 15566294]

Schneider, C.C.; Kartarius, S.; Montenarh, M.; Orzeszko, A.; Kazimierczuk, Z. Modified tetrahalogenated benzimidazoles with CK2 inhibitory activity are active against human prostate cancer cells LNCaP in vitro. Bioorg. Med. Chem., 2012, 20(14), 4390-4396.
[http://dx.doi.org/10.1016/j.bmc.2012.05.038] [PMID: 22698781]

Keurulainen, L.; Vahermo, M.; Puente-Felipe, M.; Sandoval-Izquierdo, E.; Crespo-Fernández, B.; Guijarro-López, L.; Huertas-Valentín, L.; de las Heras-Dueña, L.; Leino, T.O.; Siiskonen, A.; Ballell-Pages, L.; Sanz, L.M.; Castañeda-Casado, P.; Jiménez-Díaz, M.B.; Martínez-Martínez, M.S.; Viera, S.; Kiuru, P.; Calderón, F.; Yli-Kauhaluoma, J. A developability-focused optimization approach allows identification of in vivo fast-acting antimalarials: N-[3-[(Benzimidazol-2-yl)amino]propyl]amides. J. Med. Chem., 2015, 58(11), 4573-4580.
[http://dx.doi.org/10.1021/acs.jmedchem.5b00114] [PMID: 25906200]

Rivara, M.; Zuliani, V.; Cocconcelli, G.; Morini, G.; Comini, M.; Rivara, S.; Mor, M.; Bordi, F.; Barocelli, E.; Ballabeni, V.; Bertoni, S.; Plazzi, P.V. Synthesis and biological evaluation of new non-imidazole H3-receptor antagonists of the 2-aminobenzimidazole series. Bioorg. Med. Chem., 2006, 14(5), 1413-1424.
[http://dx.doi.org/10.1016/j.bmc.2005.09.063] [PMID: 16263297]

Ognyanov, V.I.; Balan, C.; Bannon, A.W.; Bo, Y.; Dominguez, C.; Fotsch, C.; Gore, V.K.; Klionsky, L.; Ma, V.V.; Qian, Y.X.; Tamir, R.; Wang, X.; Xi, N.; Xu, S.; Zhu, D.; Gavva, N.R.; Treanor, J.J.; Norman, M.H.; Norman, M.H. Design of potent, orally available antagonists of the transient receptor potential vanilloid 1. Structure-activity relationships of 2-piperazin-1-yl-1H-benzimidazoles. J. Med. Chem., 2006, 49(12), 3719-3742.
[http://dx.doi.org/10.1021/jm060065y] [PMID: 16759115]

Shao, B.; Huang, J.; Sun, Q.; Valenzano, K.J.; Schmid, L.; Nolan, S. 4-(2-Pyridyl)piperazine-1-benzimidazoles as potent TRPV1 antagonists. Bioorg. Med. Chem. Lett., 2005, 15(3), 719-723.
[http://dx.doi.org/10.1016/j.bmcl.2004.11.021] [PMID: 15664844]

Sørensen, U.S.; Strøbaek, D.; Christophersen, P.; Hougaard, C.; Jensen, M.L.; Nielsen, E.Ø.; Peters, D.; Teuber, L. Synthesis and structure-activity relationship studies of 2-(N-substituted)-aminobenzimidazoles as potent negative gating modulators of small conductance Ca2+-activated K+ channels. J. Med. Chem., 2008, 51(23), 7625-7634.
[http://dx.doi.org/10.1021/jm800809f] [PMID: 18998663]

Zhu, J.; Wu, C.F.; Li, X.; Wu, G.S.; Xie, S.; Hu, Q.N.; Deng, Z.; Zhu, M.X.; Luo, H-R.; Hong, X. Synthesis, biological evaluation and molecular modeling of substituted 2-aminobenzimidazoles as novel inhibitors of acetylcholinesterase and butyrylcholinesterase. Bioorg. Med. Chem., 2013, 21(14), 4218-4224.
[http://dx.doi.org/10.1016/j.bmc.2013.05.001] [PMID: 23719283]

Oh, S.; Kim, S.; Kong, S.; Yang, G.; Lee, N.; Han, D.; Goo, J.; Siqueira-Neto, J.L.; Freitas-Junior, L.H.; Song, R. Synthesis and biological evaluation of 2,3-dihydroimidazo[1,2-a]benzimidazole derivatives against Leishmania donovani and Trypanosoma cruzi. Eur. J. Med. Chem., 2014, 84, 395-403.
[http://dx.doi.org/10.1016/j.ejmech.2014.07.038] [PMID: 25036797]

Tamura, Y.; Omori, N.; Kouyama, N.; Nishiura, Y.; Hayashi, K.; Watanabe, K.; Tanaka, Y.; Chiba, T.; Yukioka, H.; Sato, H.; Okuno, T. Identification of a novel and orally available benzimidazole derivative as an NPY Y5 receptor antagonist with in vivo efficacy. Bioorg. Med. Chem. Lett., 2012, 22(21), 6554-6558.
[http://dx.doi.org/10.1016/j.bmcl.2012.09.025] [PMID: 23025998]

Lv, X.; Bao, W. Copper-catalyzed cascade addition/cyclization: an efficient and versatile synthesis of N-substituted 2-heterobenzimidazoles. J. Org. Chem., 2009, 74(15), 5618-5621.
[http://dx.doi.org/10.1021/jo900743y] [PMID: 19719252]

Yuan, G.; Liu, H.; Gao, J.; Yang, K.; Niu, Q.; Mao, H.; Wang, X.; Lv, X. Copper-catalyzed domino addition/double cyclization: an approach to polycyclic benzimidazole derivatives. J. Org. Chem., 2014, 79(4), 1749-1757.
[http://dx.doi.org/10.1021/jo402742k] [PMID: 24490887]

Shena, G.; Bao, W. Synthesis of benzoxazole and benzimidazole derivatives via ligand-free copper(i)-catalyzed cross-coupling reaction of o-halophenols or o-haloanilines with carbodiimides. Adv. Synth. Catal., 2010, 352, 981-986.
[http://dx.doi.org/10.1002/adsc.201000022]

Wang, F.; Cai, S.; Liao, Q.; Xi, C. A protocol to 2-aminobenzimidazoles via copper-catalyzed cascade addition and cyclization of o-haloanilines and carbodiimides. J. Org. Chem., 2011, 76(9), 3174-3180.
[http://dx.doi.org/10.1021/jo200014v] [PMID: 21413745]

He, H-F.; Wang, Z-J.; Bao, W. Copper(II) acetate/oxygen-mediated nucleophilic addition and intramolecular c-h activation/C-N or C-C bond formation: One-pot synthesis of benzimidazoles or quinazolines. Adv. Synth. Catal., 2010, 352, 2905-2912.
[http://dx.doi.org/10.1002/adsc.201000469]

Tran, L.Q.; Li, J.; Neuville, L. Copper-catalyzed domino three-component approach for the assembly of 2-aminated benzimidazoles and quinazolines. J. Org. Chem., 2015, 80(12), 6102-6108.
[http://dx.doi.org/10.1021/acs.joc.5b00614] [PMID: 26056863]

(a) Monguchi, D.; Fujiwara, T.; Furukawa, H.; Mori, A. Direct amination of azoles via catalytic C-H, N-H coupling. Org. Lett., 2009, 11(7), 1607-1610.
[http://dx.doi.org/10.1021/ol900298e] [PMID: 19254040]
(b) Monguchi, D.; Yamamura, A.; Fujiwara, T.; Somete, T.; Mori, A. Oxidative dimerization of azoles via copper(II)/silver(I)-catalyzed CH homocoupling. Tetrahedron Lett., 2010, 51, 850-852.
[http://dx.doi.org/10.1016/j.tetlet.2009.12.016]
(c) Mitsuda, Sh.; Fujiwara, T.; Kimigafukuro, K.; Monguchi, D.; Mori, A. Copper-catalyzed oxidative C‒H, N‒H coupling of azoles and thiophenes. Tetrahedron, 2012, 68, 3585-3590.
[http://dx.doi.org/10.1016/j.tet.2012.03.001]
(d) Wang, Q.; Schreiber, S.L. Copper-mediated amidation of heterocyclic and aromatic C-H bonds. Org. Lett., 2009, 11(22), 5178-5180.
[http://dx.doi.org/10.1021/ol902079g] [PMID: 19860425]
(e) Armstrong, A.; Collins, J.C. Direct azole amination: C-H functionalization as a new approach to biologically important heterocycles. Angew. Chem. Int. Ed. Engl., 2010, 49(13), 2282-2285.
[http://dx.doi.org/10.1002/anie.200906750] [PMID: 20186895]

Xu, J.; Li, J.; Wei, Zh.; Zhang, Q.; Shi, D. Direct amination of azoles using CuCl2 complexes of amines under mild conditions. RSC Advances, 2013, 3, 9622-9624.
[http://dx.doi.org/10.1039/c3ra41496e]

Wagh, Y.S.; Bhanage, B.M. Cu(acac)2 catalyzed oxidative C–H bond amination of azoles with amines under base-free conditions. Tetrahedron Lett., 2012, 53, 6500-6503.
[http://dx.doi.org/10.1016/j.tetlet.2012.09.064]

McDonald, S.L.; Hendrick, C.E.; Wang, Q. Copper-catalyzed electrophilic amination of heteroarenes and arenes by C-H zincation. Angew. Chem. Int. Ed. Engl., 2014, 53(18), 4667-4670.
[http://dx.doi.org/10.1002/anie.201311029] [PMID: 24668522]

Hendrick, C.E.; Bitting, K.J.; Cho, S.; Wang, Q. Site-selective copper-catalyzed amination and azidation of arenes and heteroarenes via deprotonative zincation. J. Am. Chem. Soc., 2017, 139(33), 11622-11628.
[http://dx.doi.org/10.1021/jacs.7b07661] [PMID: 28753007]

Deng, X.; McAllister, H.; Mani, N.S. CuI-catalyzed amination of arylhalides with guanidines or amidines: a facile synthesis of 1-H-2-substituted benzimidazoles. J. Org. Chem., 2009, 74(15), 5742-5745.
[http://dx.doi.org/10.1021/jo900912h] [PMID: 19527012]

Evindar, G.; Batey, R.A. Copper- and palladium-catalyzed intramolecular aryl guanidinylation: an efficient method for the synthesis of 2-aminobenzimidazoles. Org. Lett., 2003, 5(2), 133-136.
[http://dx.doi.org/10.1021/ol027061h] [PMID: 12529123]

Hu, Z.; Li, S-D.; Hong, P-Z.; Wu, Zh. Copper(I)-catalyzed intramolecular C-N coupling reactions to form 1-cyanobenzimidazoles. ARKIVOC, 2011, (xi), 147-155.

Hu, Z.; Ou, L.; Li, S.; Yang, L. Synthesis and biological evaluation of 1-cyano-2-aminobenzimidazole derivatives as a novel class of antitumor agents. Med. Chem. Res., 2014, 23, 3029-3038.
[http://dx.doi.org/10.1007/s00044-013-0888-6]

Saha, P.; Ramana, T.; Purkait, N.; Ali, M.A.; Paul, R.; Punniyamurthy, T. Ligand-free copper-catalyzed synthesis of substituted benzimidazoles, 2-aminobenzimidazoles, 2-aminobenzothiazoles, and benzoxazoles. J. Org. Chem., 2009, 74(22), 8719-8725.
[http://dx.doi.org/10.1021/jo901813g] [PMID: 19908912]

Chi, Y.; Zhang, W-X.; Xi, Z. Oxidant-switchable selective synthesis of 2-aminobenzimidazoles via C-H amination/acetoxylation of guanidines. Org. Lett., 2014, 16(24), 6274-6277.
[http://dx.doi.org/10.1021/ol502815p] [PMID: 25474397]

Tran, M.Q.; Ermolenko, L.; Retailleau, P.; Nguyen, T.B.; Al-Mourabit, A. Reaction of quinones and guanidine derivatives: simple access to bis-2-aminobenzimidazole moiety of benzosceptrin and other benzazole motifs. Org. Lett., 2014, 16(3), 920-923.
[http://dx.doi.org/10.1021/ol403672p] [PMID: 24479902]

Daswani, U.; Dubey, N.; Sharma, P.; Kumar, A. A new NBS/oxone promoted one pot cascade synthesis of 2-aminobenzimidazoles/2-aminobenzoxazoles: a facile approach. New J. Chem., 2016, 40, 8093-8099.
[http://dx.doi.org/10.1039/C6NJ00478D]

Taniguchi, K.; Shigenaga, S.; Ogahara, T.; Fujitsu, T.; Matsuo, M. Synthesis and antiinflammatory and analgesic properties of 2-amino-1H-benzimidazole and 1,2-dihydro-2-iminocycloheptimidazole derivatives. Chem. Pharm. Bull. (Tokyo), 1993, 41(2), 301-309.
[http://dx.doi.org/10.1248/cpb.41.301] [PMID: 8500198]

(a) Perkins, J.J.; Zartman, A.E.; Meissner, R.S. Synthesis of 2-(Alkyl-amino)benzimidazoles. Tetrahedron Lett., 1999, 40, 1103-1106.
(b) Beaulieu, C.; Wang, Z.; Denis, D.; Greig, G.; Lamontagne, S.; O’Neill, G.; Slipetz, D.; Wang, J. Benzimidazoles as new potent and selective DP antagonists for the treatment of allergic rhinitis. Bioorg. Med. Chem. Lett., 2004, 14, 3195-3199.
(c) Kling, A.; Backfisch, G.; Delzer, J.; Geneste, H.; Graef, C.; Holzenkamp, U.; Hornberger, W.; Lange, U.E.W.; Lauterbach, A.; Mack, H.; Seitz, W.; Subkowski, T. Synthesis and SAR of N-substituted dibenzazepinone derivatives as novel potent and selective RV3 antagonists. Bioorg. Med. Chem. Lett., 2002, 12, 441-446.
(d) Scheffer, U.; Strick, A.; Ludwig, V.; Peter, S.; Kalden, E.; Göbel, M.W. Metal-free catalysts for the hydrolysis of RNA derived from guanidines, 2-aminopyridines, and 2-aminobenzimidazoles. J. Am. Chem. Soc., 2005, 127, 2211-2217.

Sasikumar, T.K.; Qiang, L.; Burnett, D.A.; Greenlee, W.J.; Hawes, B.E.; Kowalski, T.J.; O’Neill, K.; Spar, B.D.; Weig, B. Novel aminobenzimidazoles as selective MCH-R1 antagonists for the treatment of metabolic diseases. Bioorg. Med. Chem. Lett., 2006, 16, 5427-5431.

Snow, R.J.; Cardozo, M.G.; Morwick, T.M.; Busacca, C.A.; Dong, Y.; Eckner, R.J.; Jacober, S.; Jakes, S.; Kapadia, S.; Lukas, S.; Panzenbeck, M.; Peet, G.W.; Peterson, J.D.; Prokopowicz, A.S., III; Sellati, R.; Tolbert, R.M.; Tschantz, M.A.; Moss, N. Discovery of 2-phenylamino-imidazo[4,5-h]iso-quinolin-9-ones: a new class of inhibitors of lck kinase. J. Med. Chem., 2002, 45(16), 3394-3405.
[http://dx.doi.org/10.1021/jm020113o] [PMID: 12139450]

Sasikumar, T.K.; Qiang, L.; Burnett, D.A.; Greenlee, W.J.; Hawes, B.E.; Kowalski, T.J.; O’Neill, K.; Spar, B.D.; Weig, B. Novel aminobenzimidazoles as selective MCH-R1 antagonists for the treatment of metabolic diseases. Bioorg. Med. Chem. Lett., 2006, 16(20), 5427-5431.
[http://dx.doi.org/10.1016/j.bmcl.2006.07.058] [PMID: 16889961]

Bendale, P.M.; Sun, C-M. Rapid microwave-assisted liquid-phase combinatorial synthesis of 2-(arylamino)benzimidazoles. J. Comb. Chem., 2002, 4(4), 359-361.
[http://dx.doi.org/10.1021/cc0200080] [PMID: 12099854]

Heinelt, U.; Schultheis, D.; Jäger, S.; Lindenmaier, M.; Pollex, A.; Beckmann, H.S.G. A convenient method for the synthesis of 2-amino substituted aza-heterocycles from N,N´-disubstituted thioureas using TsCl/NaOH. Tetrahedron, 2004, 60, 9883-9888.
[http://dx.doi.org/10.1016/j.tet.2004.08.031]

Wang, X-J.; Zhang, L.; Xu, Y.; Krishnamurthy, D.; Senanayake, C.H. A practical synthesis of 2-(N-substituted)-aminobenzimidazoles utilizing CuCl-promoted intramolecular cyclization of N-(2-aminoaryl)thioureas. Tetrahedron Lett., 2004, 45, 7167-7170.
[http://dx.doi.org/10.1016/j.tetlet.2004.07.042]

Cee, V.J.; Downing, N.S. A one-pot method for the synthesis of 2-aminobenzimidazoles and related heterocycles. Tetrahedron Lett., 2006, 47, 3747-3750.
[http://dx.doi.org/10.1016/j.tetlet.2006.03.112]

Charton, J.; Girault-Mizzi, S.; Debreu-Fontaine, M-A.; Foufelle, F.; Hainault, I.; Bizot-Espiard, J-G.; Caignard, D-H.; Sergheraert, C. Synthesis and biological evaluation of benzimidazole derivatives as potent AMP-activated protein kinase activators. Bioorg. Med. Chem., 2006, 14(13), 4490-4518.
[http://dx.doi.org/10.1016/j.bmc.2006.02.028] [PMID: 16513356]

Carpenter, R.D.; Deberdt, P.B.; Lam, K.S.; Kurth, M.J. Carbodiimide-based benzimidazole library method. J. Comb. Chem., 2006, 8(6), 907-914.
[http://dx.doi.org/10.1021/cc060106b] [PMID: 17096580]

Ghosh, H.; Yella, R.; Nath, J.; Patel, B.K. Desulfurization mediated by hypervalent iodine(III): A novel strategy for the construction of heterocycles. Eur. J. Org. Chem., 2008, 6189-6196.
[http://dx.doi.org/10.1002/ejoc.200800901]

Yella, R.; Patel, B.K. One-pot synthesis of five and six membered N, O, S-heterocycles using a ditribromide reagent. J. Comb. Chem., 2010, 12(5), 754-763.
[http://dx.doi.org/10.1021/cc100124q] [PMID: 20718465]

Xie, Y.; Zhang, F.; Li, J.; Shi, X. Novel synthesis of 2-aminobenzimidazoles from isoselenocyanates. Synlett, 2010, (6), 901-904.
[http://dx.doi.org/10.1055/s-0029-1219395]

Wan, Z-K.; Ousman, E.F.; Papaioannou, N.; Saiah, E. Phosphonium-mediated cyclization of N-(2-aminophenyl)thioureas: efficient synthesis of 2-aminobenzimidazoles. Tetrahedron Lett., 2011, 52, 4149-4152.
[http://dx.doi.org/10.1016/j.tetlet.2011.05.146]

Phakhodee, W.; Duangkamol, C.H.; Wiriya, N.; Pattarawarapan, M. Ultrasound-assisted synthesis of substituted 2-aminobenzimidazoles, 2-aminobenzoxazoles, and related heterocycles. Tetrahedron Lett., 2016, 57, 5290-5293.
[http://dx.doi.org/10.1016/j.tetlet.2016.10.060]

Krasikovs, A.; Ozola, V.; Dax, S.L.; Suna, E. Iodoacetic acid is an efficient reagent for the synthesis of amino acid derived 2-aminobenzimidazoles. Synthesis, 2013, 45, 683-693.
[http://dx.doi.org/10.1055/s-0032-1316849]

Wang, Z.; Zhao, Q.; Hou, J.; Yu, W. Chang, J. Iodine-mediated direct synthesis of multifunctional 2-aminobenzimidazoles from N-substituted o-diaminoarenes and isothiocyanates. Tetrahedron, 2018, 74, 2324-2329.
[http://dx.doi.org/10.1016/j.tet.2018.03.049]

Kondraganti, L.; Babu, S.; Dittakavi, M. Synthesis of benzimidazoles via domino intra and intermolecular C-N cross-coupling reaction. Chem. Select, 2018, 42, 11744-11748.
[http://dx.doi.org/10.1002/slct.201802754]

Das, P.; Kumar, C.K.; Kumar, K.N.; Innus, Md.; Iqbal, J.; Srinivas, N. Dithiocarbamate and CuO promoted one-pot synthesis of 2-(N-substituted)-aminobenzimidazoles and related heterocycles. Tetrahedron Lett., 2008, 49, 992-995.
[http://dx.doi.org/10.1016/j.tetlet.2007.12.022]

Su, Y-S.H.; Sun, C.H-M. Microwave-assisted benzimidazole cyclization by bismuth chloride. Synlett, 2005, (8), 1243-1246.

Hua, Z.; Huang, X.; Bregman, H.; Chakka, N.; DiMauro, E.F.; Doherty, E.M.; Goldstein, J.; Gunaydin, H.; Huang, H.; Mercede, S.; Newcomb, J.; Patel, V.F.; Turci, S.M.; Yan, J.; Wilson, C.; Martin, M.W. 2-Phenylamino-6-cyano-1H-benzimidazole-based isoform selective casein kinase 1 gamma (CK1γ) inhibitors. Bioorg. Med. Chem. Lett., 2012, 22(17), 5392-5395.
[http://dx.doi.org/10.1016/j.bmcl.2012.07.046] [PMID: 22877629]

Ramachandran, S.; Hameed, P. S.; Srivastava, A.; Shanbhag, G.; Morayya, S.; Rautela, N.; Awasthy, D.; Kavanagh, S.; Bharath, S.; Reddy, J.; Panduga, V.; Prabhakar, K.R.; Saralaya, R.; Nanduri, R.; Raichurkar, A.; Menasinakai, S.; Achar, V.; Jiménez-Díaz, M.B.; Martínez, M.S.; Angulo-Barturen, I.; Ferrer, S.; Sanz, L.M.; Gamo, F.J.; Duffy, S.; Avery, V.M.; Waterson, D.; Lee, M.C.; Coburn-Flynn, O.; Fidock, D.A.; Iyer, P.S.; Narayanan, S.; Hosagrahara, V.; Sambandamurthy, V.K. N-aryl-2-aminobenzimidazoles: Novel, efficacious, antimalarial lead compounds. J. Med. Chem., 2014, 57(15), 6642-6652.
[http://dx.doi.org/10.1021/jm500715u] [PMID: 25007124]

Kutschy, P.; Ficeri, V.; Dzurilla, M. Synthesis of 2-Acylaminobenzi-midazoles from Acyl Isothiocyanates and o-Phenylenediamine. Chem. Pap., 1994, 48, 39-42.

Seth, P.P.; Robinson, D.E.; Jefferson, E.A.; Swayze, E.E. Efficient solution phase synthesis of 2-(N-acyl)-aminobenzimidazoles. Tetrahedron Lett., 2002, 43, 7303-7306.
[http://dx.doi.org/10.1016/S0040-4039(02)01754-9]

Ding, K.; Wang, A.; Boerneke, M.A.; Dibrov, S.M.; Hermann, T. Aryl-substituted aminobenzimidazoles targeting the hepatitis C virus internal ribosome entry site. Bioorg. Med. Chem. Lett., 2014, 24(14), 3113-3117.
[http://dx.doi.org/10.1016/j.bmcl.2014.05.009] [PMID: 24856063]

Emilia, L.; Zbigniew, W. Simple Synthesis of 2-Aminoarylimino-phosphoranes from N-Aryl-2-nitrosoanilines and Their Application in 2-Aminobenzimidazoles Synthesis. Synlett, 2014, 25, 217-220.

Deasy, R.E.; Slattery, C.N.; Maguire, A.R.; Kjell, D.P.; Hawk, M.K.; Joo, J.M.; Gu, R.L.; Moynihan, H. Preparation of 2-aminopyridoimidazoles and 2-aminobenzimidazoles via phosphorus oxychloride-mediated cyclization of aminoureas. J. Org. Chem., 2014, 79(8), 3688-3695.
[http://dx.doi.org/10.1021/jo500360k] [PMID: 24641629]

Vidavalur, S.; Gajula, M.B.; Tadikonda, R.; Nakka, M.; Dega, S.; Yadav, S.K.; Voosala, Ch. PTSA catalyzed straightforward protocol for the synthesis of 2-(N-acyl)aminobenzimidazoles and 2-(N-acyl) aminobenzothiazoles in PEG. Tetrahedron Lett., 2014, 55, 2691-2694.
[http://dx.doi.org/10.1016/j.tetlet.2014.03.040]

Pollock, J.A.; Kim, S.H.; Katzenellenbogen, J.A. Imidoyl dichlorides as new reagents for the rapid formation of 2-aminobenzimidazoles and related azoles. Tetrahedron Lett., 2015, 56(44), 6097-6099.
[http://dx.doi.org/10.1016/j.tetlet.2015.09.076] [PMID: 26516292]

Wang, W.; Kong, D.; Cheng, H.; Tan, L.; Zhang, Z.; Zhuang, X.; Long, H.; Zhou, Y.; Xu, Y.; Yang, X.; Ding, K. New benzimidazole-2-urea derivates as tubulin inhibitors. Bioorg. Med. Chem. Lett., 2014, 24(17), 4250-4253.
[http://dx.doi.org/10.1016/j.bmcl.2014.07.035] [PMID: 25091926]

Nematpour, M.; Abedi, E.; Abedi, E. A novel one-pot protocol for the Cu-catalyzed synthesis of nine 2-aminobenzimidazoles derivatives from o-phenylenediamine and trichloroacetonitrile. Lett. Org. Chem., 2019, 16, 99-103.
[http://dx.doi.org/10.2174/1570178615666180914114010]